| DSCPX | VRTIX | DSCPX / VRTIX | |
| Total Expense Ratio | 0.89 | 0.07 | 1,271% |
| Annual Report Gross Expense Ratio | 0.89 | 0.07 | 1,271% |
| Fund Existence | 11 years | 15 years | - |
| Gain YTD | -6.570 | 14.503 | -45% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 661M | 14.3B | 5% |
| Annual Yield % from dividends | 0.60 | 1.17 | 52% |
| Returns for 1 year | -7.34 | 13.07 | -56% |
| Returns for 3 years | 11.64 | 46.54 | 25% |
| Returns for 5 years | -7.22 | 29.26 | -25% |
| Returns for 10 years | 86.05 | 130.53 | 66% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ELIL | 28.43 | 0.36 | +1.28% |
| Direxion Daily LLY Bull 2X Shares | |||
| AVMA | 66.80 | 0.21 | +0.32% |
| Avantis Moderate Allocation ETF | |||
| DINT | 28.88 | 0.07 | +0.25% |
| Davis Select International ETF | |||
| HYTI | 19.76 | 0.03 | +0.18% |
| FT Vest High Yield & Target Income ETF | |||
| ARKG | 30.18 | 0.04 | +0.13% |
| ARK Genomic Revolution ETF | |||